BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barrow TM, Michels KB. Epigenetic epidemiology of cancer. Biochem Biophys Res Commun. 2014;455:70-83. [PMID: 25124661 DOI: 10.1016/j.bbrc.2014.08.002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 9.1] [Reference Citation Analysis]
Number Citing Articles
1 Wei K, Ye Z, Li Z, Dang Y, Chen X, Huang N, Bao C, Gan T, Yang L, Chen G. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker. World J Surg Oncol 2016;14:34. [PMID: 26860827 DOI: 10.1186/s12957-016-0787-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
2 Ng JM, Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci. 2015;16:2472-2496. [PMID: 25622259 DOI: 10.3390/ijms16022472] [Cited by in Crossref: 85] [Cited by in F6Publishing: 68] [Article Influence: 14.2] [Reference Citation Analysis]
3 Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer. Clin Epigenetics 2015;7:74. [PMID: 26207152 DOI: 10.1186/s13148-015-0110-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
4 Al-Eitan LN, Rababa'h DM, Alghamdi MA, Khasawneh RH. Genetic association of XRCC5 gene polymorphisms with breast cancer among Jordanian women. Onco Targets Ther 2019;12:7923-8. [PMID: 31920325 DOI: 10.2147/OTT.S220226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pollock RA, Abji F, Gladman DD. Epigenetics of psoriatic disease: A systematic review and critical appraisal. Journal of Autoimmunity 2017;78:29-38. [DOI: 10.1016/j.jaut.2016.12.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 9.5] [Reference Citation Analysis]
6 Danese E, Montagnana M. Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers. Ann Transl Med 2017;5:279. [PMID: 28758105 DOI: 10.21037/atm.2017.04.45] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
7 Ciesielski TH, Aldrich MC, Marsit CJ, Hiatt RA, Williams SM. Transdisciplinary approaches enhance the production of translational knowledge. Transl Res 2017;182:123-34. [PMID: 27893987 DOI: 10.1016/j.trsl.2016.11.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
8 Chu SK, Yang HC. Interethnic DNA methylation difference and its implications in pharmacoepigenetics. Epigenomics 2017;9:1437-54. [PMID: 28882057 DOI: 10.2217/epi-2017-0046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
9 Ahmad A. Epigenetics in Personalized Management of Lung Cancer. Adv Exp Med Biol 2016;890:111-22. [PMID: 26703801 DOI: 10.1007/978-3-319-24932-2_6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
10 Ogino S, Campbell PT, Nishihara R, Phipps AI, Beck AH, Sherman ME, Chan AT, Troester MA, Bass AJ, Fitzgerald KC, Irizarry RA, Kelsey KT, Nan H, Peters U, Poole EM, Qian ZR, Tamimi RM, Tchetgen Tchetgen EJ, Tworoger SS, Zhang X, Giovannucci EL, van den Brandt PA, Rosner BA, Wang M, Chatterjee N, Begg CB. Proceedings of the second international molecular pathological epidemiology (MPE) meeting. Cancer Causes Control 2015;26:959-72. [PMID: 25956270 DOI: 10.1007/s10552-015-0596-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
11 Konicke K, López-Luna A, Muñoz-Carrillo JL, Servín-González LS, Flores-de la Torre A, Olasz E, Lazarova Z. The microRNA landscape of cutaneous squamous cell carcinoma. Drug Discov Today 2018;23:864-70. [PMID: 29317340 DOI: 10.1016/j.drudis.2018.01.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
12 Kyono Y, Sachs LM, Bilesimo P, Wen L, Denver RJ. Developmental and Thyroid Hormone Regulation of the DNA Methyltransferase 3a Gene in Xenopus Tadpoles. Endocrinology 2016;157:4961-72. [PMID: 27779916 DOI: 10.1210/en.2016-1465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
13 Karlsson Linnér R, Marioni RE, Rietveld CA, Simpkin AJ, Davies NM, Watanabe K, Armstrong NJ, Auro K, Baumbach C, Bonder MJ, Buchwald J, Fiorito G, Ismail K, Iurato S, Joensuu A, Karell P, Kasela S, Lahti J, McRae AF, Mandaviya PR, Seppälä I, Wang Y, Baglietto L, Binder EB, Harris SE, Hodge AM, Horvath S, Hurme M, Johannesson M, Latvala A, Mather KA, Medland SE, Metspalu A, Milani L, Milne RL, Pattie A, Pedersen NL, Peters A, Polidoro S, Räikkönen K, Severi G, Starr JM, Stolk L, Waldenberger M, Eriksson JG, Esko T, Franke L, Gieger C, Giles GG, Hägg S, Jousilahti P, Kaprio J, Kähönen M, Lehtimäki T, Martin NG, van Meurs JBC, Ollikainen M, Perola M, Posthuma D, Raitakari OT, Sachdev PS, Taskesen E, Uitterlinden AG, Vineis P, Wijmenga C, Wright MJ, Relton C, Davey Smith G, Deary IJ, Koellinger PD, Benjamin DJ. An epigenome-wide association study meta-analysis of educational attainment. Mol Psychiatry 2017;22:1680-90. [PMID: 29086770 DOI: 10.1038/mp.2017.210] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
14 Pinel C, Prainsack B, McKevitt C. Markers as mediators: A review and synthesis of epigenetics literature. Biosocieties 2019;13:276-303. [PMID: 31105763 DOI: 10.1057/s41292-017-0068-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
15 El Bairi K, Tariq K, Himri I, Jaafari A, Smaili W, Kandhro AH, Gouri A, Ghazi B. Decoding colorectal cancer epigenomics. Cancer Genet 2018;220:49-76. [PMID: 29310839 DOI: 10.1016/j.cancergen.2017.11.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
16 Idris S, Lindsay C, Kostiuk M, Andrews C, Côté DW, O'Connell DA, Harris J, Seikaly H, Biron VL. Investigation of EZH2 pathways for novel epigenetic treatment strategies in oropharyngeal cancer. J Otolaryngol Head Neck Surg 2016;45:54. [PMID: 27793210 DOI: 10.1186/s40463-016-0168-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
17 De Marchi T, Foekens JA, Umar A, Martens JW. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer. Drug Discov Today 2016;21:1181-8. [PMID: 27233379 DOI: 10.1016/j.drudis.2016.05.012] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
18 Mueller CA, Eme J, Burggren WW, Roghair RD, Rundle SD. Challenges and opportunities in developmental integrative physiology. Comp Biochem Physiol A Mol Integr Physiol 2015;184:113-24. [PMID: 25711780 DOI: 10.1016/j.cbpa.2015.02.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
19 Blanco-Calvo M, Concha Á, Figueroa A, Garrido F, Valladares-Ayerbes M. Colorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology Approach. Int J Mol Sci 2015;16:13610-32. [PMID: 26084042 DOI: 10.3390/ijms160613610] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
20 Falco M, Palma G, Rea D, De Biase D, Scala S, D'Aiuto M, Facchini G, Perdonà S, Barbieri A, Arra C. Tumour biomarkers: homeostasis as a novel prognostic indicator. Open Biol 2016;6:160254. [PMID: 27927793 DOI: 10.1098/rsob.160254] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
21 Straughen JK, Sipahi L, Uddin M, Misra DP, Misra VK. Racial differences in IGF1 methylation and birth weight. Clin Epigenetics 2015;7:47. [PMID: 25945130 DOI: 10.1186/s13148-015-0080-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
22 Thirumavalavan N, Gabrielsen JS, Lamb DJ. Where are we going with gene screening for male infertility? Fertil Steril 2019;111:842-50. [PMID: 31029238 DOI: 10.1016/j.fertnstert.2019.03.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
23 Guo W, Xu T, Lee JJ, Murphy GF, Lian CG. Epigenetic markers in melanoma. Melanoma Manag 2015;2:367-82. [PMID: 30190864 DOI: 10.2217/mmt.15.30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
24 Yang Y, Yin W, Wu F, Fan J. Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells. Onco Targets Ther 2017;10:2993-9. [PMID: 28652781 DOI: 10.2147/OTT.S136218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Sun R, Qin C, Jiang B, Fang S, Pan X, Peng L, Liu Z, Li W, Li Y, Li G. Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition. Mol Biosyst 2016;12:952-62. [PMID: 26798987 DOI: 10.1039/c5mb00685f] [Cited by in Crossref: 53] [Cited by in F6Publishing: 24] [Article Influence: 10.6] [Reference Citation Analysis]
26 Ma L, Bai Y, Pu H, Gou F, Dai M, Wang H, He J, Zheng T, Cheng N. Histone Methylation in Nickel-Smelting Industrial Workers. PLoS One 2015;10:e0140339. [PMID: 26474320 DOI: 10.1371/journal.pone.0140339] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
27 Relton CL, Davey Smith G. Mendelian randomization: applications and limitations in epigenetic studies. Epigenomics 2015;7:1239-43. [PMID: 26639554 DOI: 10.2217/epi.15.88] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
28 Inamura K, Song M, Jung S, Nishihara R, Yamauchi M, Lochhead P, Qian ZR, Kim SA, Mima K, Sukawa Y, Masuda A, Imamura Y, Zhang X, Pollak MN, Mantzoros CS, Harris CC, Giovannucci E, Fuchs CS, Cho E, Chan AT, Wu K, Ogino S. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. J Natl Cancer Inst 2016;108:djv363. [PMID: 26598515 DOI: 10.1093/jnci/djv363] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
29 Valdespino V, Valdespino PM. Potential of epigenetic therapies in the management of solid tumors. Cancer Manag Res 2015;7:241-51. [PMID: 26346546 DOI: 10.2147/CMAR.S70358] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 6.2] [Reference Citation Analysis]
30 Kyriazis M. Translating laboratory anti-aging biotechnology into applied clinical practice: Problems and obstacles. WJTM 2015;4:51. [DOI: 10.5528/wjtm.v4.i2.51] [Cited by in CrossRef: 1] [Article Influence: 0.2] [Reference Citation Analysis]
31 Davis A, Tao MH, Chen J, Scelo G, Bencko V, Fabianova E, Foretova L, Janout V, Lissowska J, Mates D, Mates IN, Rudnai P, Zaridze D, Boffetta P. No association between global DNA methylation in peripheral blood and lung cancer risk in nonsmoking women: results from a multicenter study in Eastern and Central Europe. Eur J Cancer Prev 2018;27:1-5. [PMID: 27045934 DOI: 10.1097/CEJ.0000000000000244] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Majnik AV, Lane RH. The relationship between early-life environment, the epigenome and the microbiota. Epigenomics 2015;7:1173-84. [DOI: 10.2217/epi.15.74] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
33 Wang M, Spiegelman D, Kuchiba A, Lochhead P, Kim S, Chan AT, Poole EM, Tamimi R, Tworoger SS, Giovannucci E, Rosner B, Ogino S. Statistical methods for studying disease subtype heterogeneity. Stat Med 2016;35:782-800. [PMID: 26619806 DOI: 10.1002/sim.6793] [Cited by in Crossref: 136] [Cited by in F6Publishing: 127] [Article Influence: 22.7] [Reference Citation Analysis]
34 Maekawa R, Mihara Y, Sato S, Okada M, Tamura I, Shinagawa M, Shirafuta Y, Takagi H, Taketani T, Tamura H, Sugino N. Aberrant DNA methylation suppresses expression of estrogen receptor 1 (ESR1) in ovarian endometrioma. J Ovarian Res 2019;12:14. [PMID: 30728052 DOI: 10.1186/s13048-019-0489-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
35 Shakeri H, Gharesouran J, Fakhrjou A, Esfahani A, Mohaddes Ardebili SM. DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification. EXCLI J 2016;15:11-20. [PMID: 27065772 DOI: 10.17179/excli2015-485] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Pisanic TR 2nd, Athamanolap P, Wang TH. Defining, distinguishing and detecting the contribution of heterogeneous methylation to cancer heterogeneity. Semin Cell Dev Biol 2017;64:5-17. [PMID: 27582426 DOI: 10.1016/j.semcdb.2016.08.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
37 Ogino S, Nowak JA, Hamada T, Phipps AI, Peters U, Milner DA, Giovannucci EL, Nishihara R, Giannakis M, Garrett WS, Song M. Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine. Gut. 2018;67:1168-1180. [PMID: 29437869 DOI: 10.1136/gutjnl-2017-315537] [Cited by in Crossref: 93] [Cited by in F6Publishing: 82] [Article Influence: 31.0] [Reference Citation Analysis]
38 Mordente A, Meucci E, Martorana GE, Silvestrini A. Cancer Biomarkers Discovery and Validation: State of the Art, Problems and Future Perspectives. In: Scatena R, editor. Advances in Cancer Biomarkers. Dordrecht: Springer Netherlands; 2015. pp. 9-26. [DOI: 10.1007/978-94-017-7215-0_2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
39 Tao Z, Shi A, Lu C, Song T, Zhang Z, Zhao J. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys. 2015;72:333-338. [PMID: 25543329 DOI: 10.1007/s12013-014-0459-6] [Cited by in Crossref: 252] [Cited by in F6Publishing: 207] [Article Influence: 63.0] [Reference Citation Analysis]
40 Langdon R, Richmond R, Elliott HR, Dudding T, Kazmi N, Penfold C, Ingarfield K, Ho K, Bretherick A, Haley C, Zeng Y, Walker RM, Pawlita M, Waterboer T, Gaunt T, Smith GD, Suderman M, Thomas S, Ness A, Relton C. Identifying epigenetic biomarkers of established prognostic factors and survival in a clinical cohort of individuals with oropharyngeal cancer. Clin Epigenetics 2020;12:95. [PMID: 32600451 DOI: 10.1186/s13148-020-00870-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kyono Y, Subramani A, Ramadoss P, Hollenberg AN, Bonett RM, Denver RJ. Liganded Thyroid Hormone Receptors Transactivate the DNA Methyltransferase 3a Gene in Mouse Neuronal Cells. Endocrinology 2016;157:3647-57. [PMID: 27387481 DOI: 10.1210/en.2015-1529] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
42 Sabit H, Tombuloglu H, Cevik E, Abdel-Ghany S, El-Zawahri E, El-Sawy A, Isik S, Al-Suhaimi E. Knockdown of c-MYC Controls the Proliferation of Oral Squamous Cell Carcinoma Cells in vitro via Dynamic Regulation of Key Apoptotic Marker Genes. Int J Mol Cell Med 2021;10:45-55. [PMID: 34268253 DOI: 10.22088/IJMCM.BUMS.10.1.45] [Reference Citation Analysis]
43 Du Y, Li M, Chen J, Duan Y, Wang X, Qiu Y, Cai Z, Gui Y, Jiang H. Promoter targeted bisulfite sequencing reveals DNA methylation profiles associated with low sperm motility in asthenozoospermia. Hum Reprod 2016;31:24-33. [PMID: 26628640 DOI: 10.1093/humrep/dev283] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
44 Nishi A, Milner DA Jr, Giovannucci EL, Nishihara R, Tan AS, Kawachi I, Ogino S. Integration of molecular pathology, epidemiology and social science for global precision medicine. Expert Rev Mol Diagn 2016;16:11-23. [PMID: 26636627 DOI: 10.1586/14737159.2016.1115346] [Cited by in Crossref: 64] [Cited by in F6Publishing: 45] [Article Influence: 10.7] [Reference Citation Analysis]
45 Perrier F, Novoloaca A, Ambatipudi S, Baglietto L, Ghantous A, Perduca V, Barrdahl M, Harlid S, Ong KK, Cardona A, Polidoro S, Nøst TH, Overvad K, Omichessan H, Dollé M, Bamia C, Huerta JM, Vineis P, Herceg Z, Romieu I, Ferrari P. Identifying and correcting epigenetics measurements for systematic sources of variation. Clin Epigenetics 2018;10:38. [PMID: 29588806 DOI: 10.1186/s13148-018-0471-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
46 Song Y, Li A, Zhang L, Duan L. Expression of G protein-coupled receptor 56 is associated with tumor progression in non-small-cell lung carcinoma patients. Onco Targets Ther 2016;9:4105-12. [PMID: 27462165 DOI: 10.2147/OTT.S106907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
47 Jenkins TG, Aston KI, Trost C, Farley J, Hotaling JM, Carrell DT. Intra-sample heterogeneity of sperm DNA methylation. MHR: Basic science of reproductive medicine 2015;21:313-9. [DOI: 10.1093/molehr/gau115] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
48 Deng J, Zhou D, Zhang J, Chen Y, Wang C, Liu Y, Zhao K. Aberrant methylation of the TERT promoter in esophageal squamous cell carcinoma. Cancer Genet 2015;208:602-9. [PMID: 26669682 DOI: 10.1016/j.cancergen.2015.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Pećina-Šlaus N, Pećina M. Only one health, and so many omics. Cancer Cell Int 2015;15:64. [PMID: 26101467 DOI: 10.1186/s12935-015-0212-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
50 Ushijima T. Cancer epigenetics: now harvesting fruit and seeding for common diseases. Biochem Biophys Res Commun 2014;455:1-2. [PMID: 25434294 DOI: 10.1016/j.bbrc.2014.11.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
51 Maekawa R, Sato S, Okada M, Lee L, Tamura I, Jozaki K, Kajimura T, Asada H, Yamagata Y, Tamura H, Yamamoto S, Sugino N. Tissue-Specific Expression of Estrogen Receptor 1 Is Regulated by DNA Methylation in a T-DMR. Mol Endocrinol 2016;30:335-47. [PMID: 26683811 DOI: 10.1210/me.2015-1058] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
52 Cordero F, Ferrero G, Polidoro S, Fiorito G, Campanella G, Sacerdote C, Mattiello A, Masala G, Agnoli C, Frasca G, Panico S, Palli D, Krogh V, Tumino R, Vineis P, Naccarati A. Differentially methylated microRNAs in prediagnostic samples of subjects who developed breast cancer in the European Prospective Investigation into Nutrition and Cancer (EPIC-Italy) cohort. CARCIN 2015;36:1144-53. [DOI: 10.1093/carcin/bgv102] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
53 Hattori N, Ushijima T. Compendium of aberrant DNA methylation and histone modifications in cancer. Biochemical and Biophysical Research Communications 2014;455:3-9. [DOI: 10.1016/j.bbrc.2014.08.140] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
54 Lan D, Zhang X, He R, Tang R, Li P, He Q, Chen G. MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance. Eur J Med Res 2015;20:50. [PMID: 25903369 DOI: 10.1186/s40001-015-0139-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
55 Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients. Clin Transl Oncol 2016;18:360-8. [DOI: 10.1007/s12094-015-1377-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
56 Lucca I, de Martino M, Klatte T, Shariat SF. Novel biomarkers to predict response and prognosis in localized bladder cancer. Urol Clin North Am 2015;42:225-33, ix. [PMID: 25882564 DOI: 10.1016/j.ucl.2015.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
57 Karageorgos I, Mizzi C, Giannopoulou E, Pavlidis C, Peters BA, Zagoriti Z, Stenson PD, Mitropoulos K, Borg J, Kalofonos HP, Drmanac R, Stubbs A, van der Spek P, Cooper DN, Katsila T, Patrinos GP. Identification of cancer predisposition variants in apparently healthy individuals using a next-generation sequencing-based family genomics approach. Hum Genomics 2015;9:12. [PMID: 26092435 DOI: 10.1186/s40246-015-0034-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kogan EA, Unanyan AL, Kadyrova AE, Demura TA, Sidorova IS, Faizullin RI, Ischenko AI. Immunohistochemical Analysis of Epigenetic Markers in Cervical Pathologies Associated with Human Papillomavirus Infection. BioNanoSci 2017;7:284-7. [DOI: 10.1007/s12668-016-0339-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
59 Perduca V, Omichessan H, Baglietto L, Severi G. Mutational and epigenetic signatures in cancer tissue linked to environmental exposures and lifestyle. Current Opinion in Oncology 2018;30:61-7. [DOI: 10.1097/cco.0000000000000418] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]